The bidirectional mood stabiliser which balances efficacy and safety

QEGINUS®

Quetiapine fumarate 25/50/100 mg

  • THE LANCET Psychiatry
  • Delivers it's VERDICT on ANTIPSYCHOTICS with Largest meta analysis
  • 101 RCTs | 20,081 participants | 68 medications in Acute Bipolar Depression
  • Quetiapine reduces depressive symptoms Rated as Category I, good confidence in the evidence
  • Reduces risk of manic switch Only drug which clearly reduced the switching risk compared to placebo